europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Library
Become a member
✕

Joint Statement on HE and Partnerships

23/11/2018
POSITION PAPER
Joint Statement on HE and Partnerships

Joint Statement on HorizonEurope and Partnerships

The six undersigned European health industry associations are ambitious about a healthier future for the European citizens, based on medical innovation, timely access to quality health interventions, better health outcomes for patients, and affordable healthcare. Horizon Europe has a key role to play in that future.

At their meeting on 30 November 2018, we encourage the Competitiveness Council to adopt a position on the Horizon Europe framework, including list of missions and partnerships, and to support the creation of a public-private partnership focused on healthcare innovation.

This positive decision will enable timely completion of the legislative process and start of Horizon Europe and its instruments, which directly support patient access to innovative healthcare solutions, Europe’s cohesion and growth, as well as the continuing attractiveness of Europe as a place for research-intensive industries and investments.

Along with our member companies and national associations, we represent a vibrant and connected research and innovation ecosystem and are committed to working together, and in partnership with all stakeholders, to ensure that Europe continues to be at the forefront of healthcare innovation for the benefit of patients. A thriving environment that enables research, innovation and deployment is essential for highly research-intensive health sectors, and for economic growth in Europe.

We therefore support the ambitions of Horizon Europe based on excellence and impact that will enhance Europe’s competitiveness in the world and of its Health Cluster with six interconnected and complementary themes. We believe that an institutional cross-sectorial public-private partnership for health research and innovation that builds on lessons from existing joint undertakings will be an important tool to achieve the Health Cluster’s ambitious goals: to increase Europe’s translational research capabilities, deliver solutions for the patients, and contribute to making our healthcare systems fit for tomorrow.

We look forward to remaining constructive partners in discussions on this important issue and urge Member States to continue joint efforts for moving the Horizon Europe legislation forward and enable the start of the programme in 2021.

COCIR: European Coordination Committee of the Radiological, Electromedical and Healthcare IT industry, www.cocir.org
EBE: Emerging Biopharmaceutical Enterprises, https://www.ebe-biopharma.eu/
EFPIA: European Federation of Pharmaceutical Industries and Associations, www.efpia.eu
EuropaBio: European Associations for Bioindustries, https://www.europabio.org/
MedTech Europe: European Association of medical technology industries comprising medical devices, diagnostics and digital health. http://www.medtecheurope.org
Vaccines Europe: https://www.vaccineseurope.eu

Download the file below to read the full Position Paper.

Joint Statement on HE and Partnerships


Download
2018_11_H_PP_Joint-Statement-on-HE-and-PartnershipsDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

06/02/2023

Delivering Europe’s ambitions in rare disease


Read more
01/02/2023

Joint Statement: The Data Act is a leap into the unknown


Read more
31/01/2023

EuropaBio’s 2022 Patient BioForum sets out recommendations to address the challenges of patients with unmet medical needs and calls for multi-stakeholder approach


Read more
17/01/2023

EuropaBio launches SME BioForum in Rare Diseases


Read more

Important links

  • Delivering Europe’s ambitions in rare disease
  • Joint Statement: The Data Act is a leap into the unknown

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies